𝔖 Bobbio Scriptorium
✦   LIBER   ✦

No correlation between RET immunostaining and the codon 918 mutation in sporadic medullary thyroid carcinoma

✍ Scribed by M. Bockhorn; A. Frilling; V. Kalinin; S. Schröder; C. E. Broelsch

Book ID
106108891
Publisher
Springer
Year
1999
Tongue
English
Weight
141 KB
Volume
384
Category
Article
ISSN
1435-2451

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutation of the RET protooncogene in spo
Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma
✍ Charis Eng; Lois M. Mulligan; Darrin P. Smith; Catherine S. Healey; Andrea Frill 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

Medullary thyroid carcinoma (MTC) occurs sporadically or as part of the inherited cancer syndrome multiple endocrine neoplasia (MEN) type 2. In MEN 2A, germline missense mutations are found in one of five cysteine codons within exons 10 and I I in the extracellular domain of the RET protooncogene. I

Distinction between sporadic and heredit
Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene
✍ Monika Fink; Andreas Weinhäusel; Bruno Niederle; Oskar A. Haas 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 614 KB

Germline and somatic mutations of the RET proto-oncogene are important pathogenetic factors in hereditary and sporadic forms of medullary thyroid carcinoma (MTC). We have therefore analysed exons 10, I I. 13, 14 and 16 of this gene in 85 individuals from 16 Austrian families who, according to clinic

Identification of a novel somatic mutati
Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma
✍ Xavier Matias-Guiu; Elena Lagarda; Monica Calaf; Arturo Azpiroz; Alberto De Leiv 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Duchenne muscular dystrophy (DMD) is an X-linked degenerative disorder of muscle, caused by gross rearrangements by the dystrophin gene in two-thirds of cases. The remaining one-third of patients may carry more subtle mutations that are difficult to detect because of the large size and complexity of